Overview

A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives

Status:
Withdrawn
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare red blood cell folate levels in women who are taking oral contraceptives with or without folic acid
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Treatments:
Contraceptive Agents
Contraceptives, Oral
Estradiol
Ethinyl Estradiol
Fluoroquinolones
Folic Acid
Moxifloxacin
Norgestimate
Norgestimate, ethinyl estradiol drug combination
Vitamin B Complex